Khloris Biosciences
Approach
Khloris Biosciences is pioneering cancer vaccination. Khloris aims to revolutionize medical treatment and the prevention of cancer and other diseases by harnessing the unlimited immunotherapeutic potential of induced pluripotent stem cells for drug discovery, vaccines and cell therapies.
Khloris Biosciences is addressing
CEO:
Lynne A. Bui, MD
Founders:
Lynne A. Bui, MD
Joseph C. Wu, MD, PhD
First investment:
December 2018